Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    IOL Chemicals is an innovation-driven bulk drug, Intermediate and Specialty Chemicals company.

    Virtual Booth

    Contact Supplier

    IKF/Pharmasynthese have been with fine chemicals market and APIs performance for more than 40 years.

    Virtual Booth

    Contact Supplier

    medac CDMO: Tailored CDMO services for injectables in syringes, cartridges & vials – aseptic, reliable, flexible and a solution ahead.

    Virtual Booth

    Contact Supplier

    Coral

    Virtual Booth

    Contact Supplier

    ICE Pharma offers a unique range of bile acid products and best-in-class services for the pharmaceutical industry.

    Virtual Booth

    Contact Supplier

    Menu

    Umeclidinium Bromide

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 185,189Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 10Anoro Ellipta

    02 8Incruse Ellipta

    03 8Trelegy Ellipta

    PharmaCompass
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    Brand Name : Trelegy Ellipta

    Fluticasone Furoate, Vilanterol Trifenatate, Umeclidinium Bromide

    arrow
    Luxepack
    Not Confirmed

    Brand Name : Trelegy Ellipta

    United Kingdom
    arrow
    Luxepack
    Not Confirmed

    GlaxoSmithKline

    Fluticasone Furoate, Vilanterol Trifenatate, Umeclidinium Bromide

    Main Therapeutic Indication : Respiratory Disorders

    Currency : USD

    2020 Revenue in Millions : 1,135

    2019 Revenue in Millions : 718

    Growth (%) : 58

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Brand Name : Incruse Ellipta

    Umeclidinium, Vilanterol

    arrow
    PREP
    Not Confirmed

    Brand Name : Incruse Ellipta

    United Kingdom
    arrow
    PREP
    Not Confirmed

    GlaxoSmithKline

    Umeclidinium, Vilanterol

    Main Therapeutic Indication : Respiratory Disorders

    Currency : USD

    2020 Revenue in Millions : 305

    2019 Revenue in Millions : 363

    Growth (%) : -16

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Brand Name : Anoro Ellipta

    Umeclidinium, Vilanterol

    arrow
    Luxepack
    Not Confirmed

    Brand Name : Anoro Ellipta

    United Kingdom
    arrow
    Luxepack
    Not Confirmed

    GlaxoSmithKline

    Umeclidinium, Vilanterol

    Main Therapeutic Indication : Respiratory Disorders

    Currency : USD

    2020 Revenue in Millions : 758

    2019 Revenue in Millions : 713

    Growth (%) : 6

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    Brand Name : Anoro Ellipta

    Umeclidinium, Vilanterol

    arrow
    Luxepack
    Not Confirmed

    Brand Name : Anoro Ellipta

    United Kingdom
    arrow
    Luxepack
    Not Confirmed

    GlaxoSmithKline

    Umeclidinium, Vilanterol

    Main Therapeutic Indication : Respiratory Disorders

    Currency : USD

    2021 Revenue in Millions : 682

    2020 Revenue in Millions : 749

    Growth (%) : -8

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    Brand Name : Incruse Ellipta

    Umeclidinium, Vilanterol

    arrow
    Luxepack
    Not Confirmed

    Brand Name : Incruse Ellipta

    United Kingdom
    arrow
    Luxepack
    Not Confirmed

    GlaxoSmithKline

    Umeclidinium, Vilanterol

    Main Therapeutic Indication : Respiratory Disorders

    Currency : USD

    2021 Revenue in Millions : 277

    2020 Revenue in Millions : 301

    Growth (%) : -7

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    Brand Name : Trelegy Ellipta

    Fluticasone Furoate, Vilanterol Trifenatate, Umeclidinium Bromide

    arrow
    Luxepack
    Not Confirmed

    Brand Name : Trelegy Ellipta

    United Kingdom
    arrow
    Luxepack
    Not Confirmed

    GlaxoSmithKline

    Fluticasone Furoate, Vilanterol Trifenatate, Umeclidinium Bromide

    Main Therapeutic Indication : Respiratory Disorders

    Currency : USD

    2021 Revenue in Millions : 1,647

    2020 Revenue in Millions : 1,122

    Growth (%) : 49

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    Brand Name : Trelegy Ellipta

    Fluticasone Furoate, Vilanterol Trifenatate, Umeclidinium Bromide

    arrow
    Luxepack
    Not Confirmed

    Brand Name : Trelegy Ellipta

    United Kingdom
    arrow
    Luxepack
    Not Confirmed

    GSK

    Fluticasone Furoate, Vilanterol Trifenatate, Umeclidinium Bromide

    Main Therapeutic Indication : Respiratory Diseases

    Currency : USD

    2022 Revenue in Millions : 2,132

    2021 Revenue in Millions : 1,647

    Growth (%) : 29

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    Brand Name : Incruse Ellipta

    Umeclidinium, Vilanterol

    arrow
    Luxepack
    Not Confirmed

    Brand Name : Incruse Ellipta

    United Kingdom
    arrow
    Luxepack
    Not Confirmed

    GSK

    Umeclidinium, Vilanterol

    Main Therapeutic Indication : Respiratory Diseases

    Currency : USD

    2022 Revenue in Millions : 242

    2021 Revenue in Millions : 277

    Growth (%) : -13

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    09

    Brand Name : Anoro Ellipta

    Umeclidinium, Vilanterol

    arrow
    Luxepack
    Not Confirmed

    Brand Name : Anoro Ellipta

    United Kingdom
    arrow
    Luxepack
    Not Confirmed

    GSK

    Umeclidinium, Vilanterol

    Main Therapeutic Indication : Respiratory Diseases

    Currency : USD

    2022 Revenue in Millions : 595

    2021 Revenue in Millions : 682

    Growth (%) : -13

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    10

    Brand Name : Trelegy Ellipta

    Fluticasone Furoate, Vilanterol Trifenatate, Umeclidinium Bromide

    arrow
    Luxepack
    Not Confirmed

    Brand Name : Trelegy Ellipta

    United Kingdom
    arrow
    Luxepack
    Not Confirmed

    GSK

    Fluticasone Furoate, Vilanterol Trifenatate, Umeclidinium Bromide

    Main Therapeutic Indication : Respiratory Diseases

    Currency : USD

    2023 Revenue in Millions : 2,377

    2022 Revenue in Millions : 2,132

    Growth (%) : 27

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF